Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 358

1.

Familial Hypercholesterolemia: Cascade Screening in Children and Relatives of the Affected.

Setia N, Saxena R, Sawhney JPS, Verma IC.

Indian J Pediatr. 2018 Feb 15. doi: 10.1007/s12098-017-2589-5. [Epub ahead of print]

PMID:
29450819
2.

Impact of Genetic Defects on Coronary Atherosclerosis among Turkish Cypriots.

Conkbayir C, Fahrioglu Yamaci R, Gencer P, Barin B, Yucel G, Yildiz CE, Ugurlucan M, Basak AN.

Heart Surg Forum. 2017 Oct 30;20(5):E223-E229. doi: 10.1532/hsf.1587.

PMID:
29087287
3.

Angiopoietin-like 3 in lipoprotein metabolism.

Kersten S.

Nat Rev Endocrinol. 2017 Dec;13(12):731-739. doi: 10.1038/nrendo.2017.119. Epub 2017 Oct 6. Review.

PMID:
28984319
4.

A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels.

Khetarpal SA, Zeng X, Millar JS, Vitali C, Somasundara AVH, Zanoni P, Landro JA, Barucci N, Zavadoski WJ, Sun Z, de Haard H, Toth IV, Peloso GM, Natarajan P, Cuchel M, Lund-Katz S, Phillips MC, Tall AR, Kathiresan S, DaSilva-Jardine P, Yates NA, Rader DJ.

Nat Med. 2017 Sep;23(9):1086-1094. doi: 10.1038/nm.4390. Epub 2017 Aug 21.

5.

[Valve Replacement for Severe Aortic Stenosis in a Patient with Tangier Disease].

Tamura A, Yoshizaki T, Kusadokoro S.

Kyobu Geka. 2017 Aug;70(9):762-764. Japanese.

PMID:
28790243
6.

PCSK9 inhibitors - from discovery of a single mutation to a groundbreaking therapy of lipid disorders in one decade.

Jaworski K, Jankowski P, Kosior DA.

Arch Med Sci. 2017 Jun;13(4):914-929. doi: 10.5114/aoms.2017.65239. Epub 2017 Jan 19.

7.

Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease.

Dewey FE, Gusarova V, Dunbar RL, O'Dushlaine C, Schurmann C, Gottesman O, McCarthy S, Van Hout CV, Bruse S, Dansky HM, Leader JB, Murray MF, Ritchie MD, Kirchner HL, Habegger L, Lopez A, Penn J, Zhao A, Shao W, Stahl N, Murphy AJ, Hamon S, Bouzelmat A, Zhang R, Shumel B, Pordy R, Gipe D, Herman GA, Sheu WHH, Lee IT, Liang KW, Guo X, Rotter JI, Chen YI, Kraus WE, Shah SH, Damrauer S, Small A, Rader DJ, Wulff AB, Nordestgaard BG, Tybjærg-Hansen A, van den Hoek AM, Princen HMG, Ledbetter DH, Carey DJ, Overton JD, Reid JG, Sasiela WJ, Banerjee P, Shuldiner AR, Borecki IB, Teslovich TM, Yancopoulos GD, Mellis SJ, Gromada J, Baras A.

N Engl J Med. 2017 Jul 20;377(3):211-221. doi: 10.1056/NEJMoa1612790. Epub 2017 May 24.

8.

New data on familial hypercholesterolaemia and acute coronary syndromes: The promise of PCSK9 monoclonal antibodies in the light of recent clinical trials.

Ellis KL, Pang J, Schultz CJ, Watts GF.

Eur J Prev Cardiol. 2017 Jul;24(11):1200-1205. doi: 10.1177/2047487317708890. Epub 2017 May 9.

PMID:
28482694
9.

Polygenic risk score predicts prevalence of cardiovascular disease in patients with familial hypercholesterolemia.

Paquette M, Chong M, Thériault S, Dufour R, Paré G, Baass A.

J Clin Lipidol. 2017 May - Jun;11(3):725-732.e5. doi: 10.1016/j.jacl.2017.03.019. Epub 2017 Apr 6.

PMID:
28456682
10.

Enhanced status of inflammation and endothelial activation in subjects with familial hypercholesterolaemia and their related unaffected family members: a case control study.

Rahman T, Hamzan NS, Mokhsin A, Rahmat R, Ibrahim ZO, Razali R, Thevarajah M, Nawawi H.

Lipids Health Dis. 2017 Apr 24;16(1):81. doi: 10.1186/s12944-017-0470-1.

11.

A rare splice donor mutation in the haptoglobin gene associates with blood lipid levels and coronary artery disease.

Bjornsson E, Helgason H, Halldorsson G, Helgadottir A, Gylfason A, Kehr B, Jonasdottir A, Jonasdottir A, Sigurdsson A, Oddsson A, Thorleifsson G, Magnusson OT, Gretarsdottir S, Zink F, Kristjansson RP, Asgeirsdottir M, Swinkels DW, Kiemeney LA, Eyjolfsson GI, Sigurdardottir O, Masson G, Olafsson I, Thorgeirsson G, Holm H, Thorsteinsdottir U, Gudbjartsson DF, Sulem P, Stefansson K.

Hum Mol Genet. 2017 Jun 15;26(12):2364-2376. doi: 10.1093/hmg/ddx123.

PMID:
28398513
12.

Impact of gain-of-function mutations in the low-density lipoprotein receptor-related protein 5 (LRP5) on glucose and lipid homeostasis.

Foer D, Zhu M, Cardone RL, Simpson C, Sullivan R, Nemiroff S, Lee G, Kibbey RG, Petersen KF, Insogna KL.

Osteoporos Int. 2017 Jun;28(6):2011-2017. doi: 10.1007/s00198-017-3977-4. Epub 2017 Mar 10.

PMID:
28283687
13.

Familial Hypercholesterolemia Phenotype in Chinese Patients Undergoing Coronary Angiography.

Li JJ, Li S, Zhu CG, Wu NQ, Zhang Y, Guo YL, Gao Y, Li XL, Qing P, Cui CJ, Xu RX, Jiang ZW, Sun J, Liu G, Dong Q.

Arterioscler Thromb Vasc Biol. 2017 Mar;37(3):570-579. doi: 10.1161/ATVBAHA.116.308456. Epub 2016 Dec 8.

PMID:
27932355
14.

Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions.

Ellis KL, Pang J, Chan DC, Hooper AJ, Bell DA, Burnett JR, Watts GF.

J Clin Lipidol. 2016 Nov - Dec;10(6):1329-1337.e3. doi: 10.1016/j.jacl.2016.08.011. Epub 2016 Aug 26.

PMID:
27919349
15.

Correlation analysis between ApoM gene-promoter polymorphisms and coronary heart disease.

Zhang Y, Huang LZ, Yang QL, Liu Y, Zhou X.

Cardiovasc J Afr. 2016 Jul/Aug;27(4):228-237. doi: 10.5830/CVJA-2016-001.

16.

c.*84G>A Mutation in CETP Is Associated with Coronary Artery Disease in South Indians.

Ganesan M, Nizamuddin S, Katkam SK, Kumaraswami K, Hosad UK, Lobo LL, Kutala VK, Thangaraj K.

PLoS One. 2016 Oct 21;11(10):e0164151. doi: 10.1371/journal.pone.0164151. eCollection 2016.

17.

Using human genetics to discover new therapeutic targets for plasma lipids.

Cohen JC.

J Intern Med. 2016 Nov;280(5):487-495. doi: 10.1111/joim.12521. Epub 2016 Oct 14. Review.

PMID:
27739219
18.

SCARB1 Gene Variants Are Associated With the Phenotype of Combined High High-Density Lipoprotein Cholesterol and High Lipoprotein (a).

Yang X, Sethi A, Yanek LR, Knapper C, Nordestgaard BG, Tybjærg-Hansen A, Becker DM, Mathias RA, Remaley AT, Becker LC.

Circ Cardiovasc Genet. 2016 Oct;9(5):408-418. Epub 2016 Sep 20.

19.

Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: Insights from SAFEHEART registry.

Alonso R, Díaz-Díaz JL, Arrieta F, Fuentes-Jiménez F, de Andrés R, Saenz P, Ariceta G, Vidal-Pardo JI, Almagro F, Argueso R, Prieto-Matos P, Miramontes JP, Pintó X, Rodriguez-Urrego J, Perez de Isla L, Mata P.

J Clin Lipidol. 2016 Jul-Aug;10(4):953-961. doi: 10.1016/j.jacl.2016.04.006. Epub 2016 Apr 21.

PMID:
27578128
20.

A single-nucleotide polymorphism C-724 /del in the proter region of the apolipoprotein M gene is associated with type 2 diabetes mellitus.

Zhang PH, Gao JL, Pu C, Feng G, Wang LZ, Huang LZ, Zhang Y.

Lipids Health Dis. 2016 Aug 30;15:142. doi: 10.1186/s12944-016-0307-3.

Supplemental Content

Loading ...
Support Center